NautaDutilh has assisted Partners Group, the global private markets firm, together with Ropes & Gray on its acquisition of Pharmathen, a leading European pharmaceutical company, from the international investment firm BC Partners. The transaction values Pharmathen at an enterprise value of around EUR 1.6 billion.
Founded in 1969, Pharmathen is a leading contract development and manufacturing organization specialized in advanced drug delivery technologies for complex generic pharmaceutical products.
The NautaDutilh team was led by corporate partner Rebecca Runa Pinto - Noome and further consisted of Jos Somers (Corporate M&A), Greet Wilkenhuysen, Caroline Notté (Corporate Luxembourg), Elizabeth van Schilfgaarde, Marc Orval, (Finance), Aira Scheijvens, Ruben Martens (Corporate Notarial), Nina Kielman (Tax), Jolize Lautenbach (Public law), Jeroen Boelens (Pharma/IP), Daniël Kuiper (Employment), Josée Weydert (Finance), David Al Mari (Corporate), Vasiliki Gerou (Finance) and Sarah Sorensen (Corporate).
Partners Group is a leading global private markets firm. Partners Group's private equity team has invested more than USD 5 billion in Health & Life companies on behalf of its clients since inception.